Pfizer Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Crore)
Pfizer Ltd · Outcome · 03 Nov 2026, 7:44 pm
Pfizer Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Crore) ■ Revenue: 727 (+13.2% YoY | +11.3% QoQ) ■ EBITDA: 261 (+13.6% YoY | +5.5% QoQ) ■ EBITDA Margin (%): 35.9 (+14 bps YoY | -197 bps QoQ) ■ PAT: 313 (+65.7% YoY | +53.2% QoQ) ■ EPS (INR): 47.1 (+14.0% YoY | +5.4% QoQ)
Original exchange filing (PDF)
More announcements from Pfizer Ltd
- Please find enclosed unaudited financial results for the quarter and half year ended September 30, 2026 along with the limited review report. · 03 Nov 2026
- Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve This is to inform you that a meeting .... · 03 Nov 2026
- Pfizer Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 03 Nov 2026
- This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 03 Nov 2026
- Intimation for order issued by the Deputy/Additional Commissioner of Income Tax Transfer Pricing. · 29 Sept 2026
- Intimation regarding change in Senior Management Personnel of the Company. · 18 Sept 2026
- Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026. · 07 Sept 2026
- Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026. · 07 Sept 2026
